CAY10502 is a potent and selective inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ). It is primarily utilized in research settings to study its effects on cellular signaling pathways, particularly those involved in inflammation and immune responses. By inhibiting PI3Kγ, it serves as a valuable tool for understanding the molecular mechanisms underlying these processes. Researchers often use it to explore potential therapeutic applications in diseases characterized by excessive inflammation or aberrant immune activity, such as autoimmune disorders and chronic inflammatory diseases. Additionally, CAY10502 is employed in pharmacological studies to assess its efficacy and safety profile, contributing to the development of novel treatments. Its role in modulating key biological pathways also makes it a candidate for investigating cancer biology and potential anti-cancer strategies, given PI3Kγ's involvement in cell growth and survival.